Caterina Maugeri

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 8 EPO patents. Top assignee: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.. Active years: 2009-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Caterina Maugeri. Retrieved from https://idiyas.com/inventor/caterina-maugeri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 16.7

CIPO Patents = 5

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

12 out of 106

Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.

patents

Years Active: 2009-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10160746 - 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors (2018-12-25),

2. 10005730 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2018-06-26),

3. 9611249 - 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors (2017-04-04),

4. 9249097 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2016-02-02),

5. 8871948 - (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor (2014-10-28),

6. 8686021 - [object Object] (2014-04-01),

7. 8637682 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2014-01-28),

8. 8507528 - 2-alkyl-indazole compounds for the treatment of certain cns-related disorders (2013-08-13),

9. 8399477 - (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor (2013-03-19),

10. 8017644 - 2-arylindole derivatives as nPGES-1 inhibitors (2011-09-13),

11. 7667069 - Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it (2010-02-23),

12. 7524886 - L-(−)-moprolol L-(+)-tartrate (2009-04-28),

Title: Innovator Caterina Maugeri: Pioneering Advances in Pharmaceutical Compounds

Introduction

Caterina Maugeri is a remarkable inventor based in Rome, Italy, known for her significant contributions to the field of pharmaceuticals. With an impressive portfolio of 12 patents, she is dedicated to developing innovative compounds that address various healthcare challenges. Her latest inventions focus on inhibitors that impact critical biological processes.

Latest Patents

One of Caterina's notable patents is the "1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors." This groundbreaking invention pertains to compounds that inhibit glycogen synthase kinase 3 beta (GSK-3β), with potential applications in treating GSK-3β-related disorders such as insulin-resistance disorders, neurodegenerative diseases, mood disorders, and various cancers.

Another key patent is for a "3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor." This invention relates to novel benzoyl derivatives of 3-aminocarbazole that possess therapeutic potential in treating conditions linked to the production of prostaglandin E (PGE), including inflammatory processes, pain, and Alzheimer's disease.

Career Highlights

Caterina Maugeri's career is marked by her innovative spirit and dedication to research and development. She has consistently focused on creating pharmaceutical solutions that address critical health issues. Her work at the esteemed Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. showcases her commitment to advancing medicine through inventive thinking and scientific exploration.

Collaborations

Throughout her career, Caterina has collaborated with notable colleagues such as Nicola Cazzolla and Maria Alessandra Alisi. These partnerships highlight the importance of teamwork and diversity in driving forward groundbreaking research and enhancing the efficacy of the innovations they produce.

Conclusion

Caterina Maugeri stands out as a leading innovator in the pharmaceutical industry, with her patents offering promising solutions to various health conditions. Her contributions reflect the potential of innovation to transform healthcare and improve the quality of life for individuals affected by complex disorders. As she continues her work, the impact of her inventions will undoubtedly resonate within the medical community and beyond.

Profile summary based on public USPTO records.